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Dietary sodium and potassium contribute to the control of
the blood pressure. Endothelial cells are targets for
aldosterone, which activates the apically located epithelial
sodium channels. The activity of these channels is negatively
correlated with the release of nitric oxide (NO) and
determines endothelial function. A mediating factor between
channel activity and NO release is the mechanical stiffness of
the cell’s plasma membrane, including the submembranous
actin network (the cell’s ‘shell’). Changes in plasma sodium
and potassium, within the physiological range, regulate
the viscosity of this shell and thus control the shear-
stress-dependent activity of the endothelial NO synthase
located in the shell’s ‘pockets’ (caveolae). High plasma
sodium gelates the shell of the endothelial cell, whereas the
shell is fluidized by high potassium. Accordingly, this concept
envisages that communications between extracellular ions
and intracellular enzymes occur at the plasma membrane
barrier, whereas 90% of the total cell mass remains
uninvolved in these changes. Endothelial cells are highly
sensitive to extracellular sodium and potassium. This
sensitivity may serve as a physiological feedback mechanism
to regulate local blood flow. It may also have
pathophysiological relevance when sodium/potassium
homeostasis is disturbed.
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POSSIBLE CLINICAL RELEVANCE OF ENDOTHELIAL CELL
STIFFNESS
In physics, the term stiffness is clearly defined: ‘Stiffness is a
measure of the resistance offered by an elastic body to
deformation’. In cellular physiology stiffness is the force
(Newton) necessary to compress a cell for a certain distance
(meter). Force is applied to most tissues in real life, particularly
to vascular endothelium. Hemodynamic forces, generated by the
beating heart, give rise to shear stress at the endothelial surface. It
is inevitable therefore that the apical cell surfaces undergo
reversible deformations and that it is this mechanical stimulus
that triggers the activity of the endothelial nitric oxide synthase
(eNOS) and the release of nitric oxide (NO).1 The NO diffuses
to the adjacent vascular smooth muscle cells, which relax leading
to vasodilation. This regulatory mechanism distributes the blood
in the organism according to the metabolic demands whereas
the systemic blood pressure is maintained within physiological
limits. The same shear force should cause a stiff (less deformable)
cell to release less NO. Therefore, endothelial mechanical stiffness
is a key parameter in the control of local blood supply and
arterial blood pressure (Figure 1).
ATOMIC FORCE MICROSCOPE: A MECHANICAL NANOSENSOR
The ‘tool of choice’ for quantitatively measuring the stiffness
(given in N/m) of living adherent endothelial cells is an atomic
force microscope (AFM). In principle, the AFM is used as a
mechanical tool. The tip of the AFM (sometimes shaped to be
a small sphere) is pressed against the cell so that the membrane
is indented (Figure 2). This distorts the cantilever on the AFM
that serves as a soft spring. The cantilever deflection, measured
by a laser beam, is reflected from the gold-coated cantilever
surface, which permits force–distance curves of single cells to
be measured. The slope of such curves is directly related to the
force (expressed in Newton) necessary to indent the cell for a
given distance (expressed in meter). At least two different
slopes can be identified depending on the depth of indenta-
tion. The initial rather flat slope (indentation depth: up to a
several 100 nm) reflects the stiffness of the soft plasma
membrane including the cortical cytoskeleton (the cell’s
‘shell’), whereas the late rather steep slope reflects the stiffness
of the more rigid cell center.2
SODIUM: ‘STIFFENER’ OF VASCULAR ENDOTHELIAL CELLS
For more than three million years primitive man consumed
less than 1 g per day of sodium chloride.3 About 8000 years
ago, with the advent of agriculture and farming,
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sodium chloride consumption increased to about 10 g per
day. The main reason was to preserve foods such as bread and
meat. Salt became precious because it allowed food to be
stored for prolonged periods.4 For instance Christopher
Columbus would have never discovered the West Indies
without the use of salt to keep fish, meat, and bread from
perishing. Although the German engineer Carl von Linde
invented the refrigerator more than 130 years ago, which has
enabled food to be stored by deep-freezing, modern society
has not yet returned to the low levels of sodium consumed
during primitive times. As life expectation is nowadays close
to 80 years, the harmful effects of high-salt diets has become
increasingly apparent. Hypertension, stroke, coronary heart
disease, and renal fibrosis are related to a high sodium
intake.5 Although the deleterious effects of a high sodium
intake are now obvious, the underlying mechanisms how
sodium chloride exerts its effect at the organ, tissue, and
cellular levels are still unclear. A high sodium intake causes
fibrosis and inflammatory processes in the kidney and heart.6
When dietary salt intake exceeds renal excretory capacity an
increased amount of sodium is stored in the space between
cells, bound to extracellular organic material.7 Plasma
sodium is raised in hypertension (by 3–4mmol/l) when
dietary sodium intake is raised.8 It has therefore been postu-
lated that changes in plasma sodium per se may control the
blood pressure. Accordingly, the effect of such small changes
in sodium concentration on endothelial function has been
studied. It was found that when extracellular sodium is raised
in this manner endothelial cells stiffen within minutes9 and
that this only occurs in the presence of aldosterone. It is
remarkable, however, that endothelial cells appear insensitive
to sodium concentrations below 139mmol/l, above which,
however, they are highly sensitive (Figure 3). This type of
experiment is technically challenging as buffered solutions
that differ by only 2mmol/l sodium are difficult to prepare
and handle. It is emphasized that the endothelium’s response
to the changes in sodium concentration is strictly dependent
on aldosterone. Inhibition of the cytosolic mineralocorticoid
receptors by spironolactone (or eplerenone) prevents en-
dothelial stiffening as does inhibition of the epithelial sodium
channel (ENaC; present in the apical plasma membrane of
endothelia) by amiloride.9 These in vitro experiments may
explain the protective action of these two substances on the
cardiovascular system.10,11 The data strongly support the
view that the blood vessels and the heart are primary targets
for diuretics, independent of any actions they may have on
the kidney.
POTASSIUM: SOFTENER OF VASCULAR ENDOTHELIAL CELLS
Besides a genetic predisposition for hypertension,12 it is
the amount of the daily sodium and potassium intake that
may lead to onset of elevated blood pressure in the otherwise
healthy individual. In contrast to natural food, processed
food products are rich in sodium and poor in potassium.
There is general agreement that a high-potassium, low-
sodium diet exerts beneficial effects on the cardio-
vascular system13 and may even influence emotion such as
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Figure 2 | Indentation technique using atomic force
microscopy. Indentation curve with two different slopes
(modified from Oberleithner et al.15).
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Figure 3 |Relationship between cell stiffness and electrolyte
concentrations. Please note that the electrolyte-induced changes
in stiffness occur within minutes. Numbers close to the mean
values (±s.e.m.) are the respective ion concentrations in the
extracellular solution (mmol/l) (modified from Oberleithner
et al.9,15).
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Figure 1 |Concept of how the mechanical stiffness of
endothelial cells participates in the regulation of blood
pressure.
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depression, tension, and vigor.14 Potassium deficiency is
difficult to detect for 98% of body potassium is intracellular.
Plasma potassium is maintained within narrow limits and is a
subtle indicator for any disturbances of potassium home-
ostasis. For this reason we studied the effect of extracellular
potassium on endothelial cells (Figure 3). It was found that
extracellular potassium concentrations above 5mmol/l swell
and soften endothelial cells.15 Plasma potassium is often
raised in kidney disease but ‘local’ potassium concentrations
greater than 5mmol/l, are absolutely normal in muscle
during physical exercise16 and in the brain during increased
neuronal activity17 while overall electrolyte homeostasis is
unaffected.
The extent of potassium-induced cell softening depends
on the absence or presence of aldosterone and the
concentration of extracellular sodium. When extracellular
sodium is low and aldosterone is absent (an experimental
rather than a physiological condition), a 27% decrease
in endothelial cell stiffness can be induced by raising the
concentration of potassium from 4 to 6mmol/l. In the
presence of aldosterone and extracellular sodium in the low
physiological range (a more realistic situation in humans),
the same maneuver causes stiffness to decrease by 21%.
However, if aldosterone is present and extracellular sodium is
in the high range (a pathophysiological condition), then the
decrease in stiffness induced by a rise in potassium from 4 to
6mmol/l is only about 6%, a change which is not statistically
significant.15 It is true that these observed interactions bet-
ween extracellular sodium and potassium are taking place
under well-controlled conditions in vitro. Though the
situation may be different in vivo, it is clear that stiffness
and NO release are inversely related.
ENDOTHELIAL NO RELEASE: OPPOSING ROLES OF SODIUM
AND POTASSIUM
Endothelial nitric oxide synthase is located at the caveoli of
the apical cell membrane and its expression and/or activity is
regulated by various factors. It is stimulated by increases
in intracellular Ca2þ (through calmodulin) independent
of the initial stimulus. Besides the fact that NO synthase
isoenzymes are associated with more than 20 interacting
proteins,18 it is likely that sodium ions control eNOS activity,
which is also inhibited by aldosterone,19 possibly indirectly
through EnaC-mediated sodium influx. Conversely, inhibi-
tion of ENaC-mediated sodium influx by amiloride activates
eNOS.20 An increase in the intake of salt induces the
production of asymmetrical dimethyl-L-arginine, which is a
competitive eNOS inhibitor,21 and increasing extracellular
sodium within the physiological range, as illustrated in
Figure 2, downregulates eNOS expression and angiogenesis.22
In Figure 4 data from two reports9,15 on cell stiffness and NO
release (measured as nitrite in the supernatant of shear-stress-
activated endothelial cells in vitro) are combined in a single
graph. It is noticeable that (1) there is a negative correlation
between stiffness and eNOS activity, (2) extracellular sodium
concentration strongly determines stiffness and eNOS
function, and (3) extracellular potassium concentration
influences eNOS activity and stiffness only at low sodium
concentrations. All the experiments contributing to Figure 4
were performed in the presence of concentrations of
aldosterone similar to those found in physiological conditions.
A big question remains: does eNOS activity depend on cell
stiffness (as proposed above) or vice versa? In other words
does the cell’s deformability determine eNOS activity or does
this activity ‘itself ’ modify the cell’s mechanical compliance
to enable the endothelium to better adjust to the large
changes in morphology that inevitably occur when blood
vessels recurrently dilate and contract?
‘SOLATION–GELATION’ HYPOTHESIS
Vascular endothelial cells undergo large changes in shape
(e.g., during vascular dilation/constriction, particularly in
those that occur with each contraction of the heart) and can
best adjust to such alterations if the deformability (physical
compliance) of the cells is high. The AFM analysis reveals at
least two linear slopes in the indentation curves; the first
tends to be flat whereas the second is steeper (Figure 2). The
first flatter slope indicates a low stiffness, which is limited to
the submembranous cortex of the cell (the cell’s shell). The
nature of the slope indicates clearly that there is a fluidic layer
immediately beneath the plasma membrane, which is highly
changeable in terms of thickness and viscosity. The cortical
cytoskeleton of vascular endothelial cells is highly ‘dynamic’
and the state of polymerization of cortical actin determines
the structure and mechanical properties of this layer.2,23
Monomeric globular actin (G-actin), which can rapidly
polymerize into filamentous actin (F-actin), can cause a rapid
increase in local viscosity (gelation). Alternatively, switching
from F-actin to G-actin using the polymerization inhibitor
cytochalasin D is associated with solation of the cortex (i.e.,
the submembranous multimeric actin filament meshwork
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Figure 4 |Negative correlation between cell stiffness and
nitric oxide (NO) release. NO release was derived from the nitrite
concentrations measured in the supernatant culture media. Data
were taken from Oberleithner et al.9,15
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disaggregates into actin monomers).15 An increase in extra-
cellular potassium mimicks this response indicating that
potassium per se (or, more indirectly, through changes of the
membrane potential; see below) softens the cortical actin
cytoskeleton by changing F-actin to G-actin. G-actin is
known to colocalize with eNOS and to increase eNOS
activity.24 This could explain the activation of eNOS by high
potassium.
It is possible that in this system sodium is a functional
antagonist. Sodium influx, mediated by aldosterone-activated
ENaC, stiffens the cytoskeleton by increasing the viscosity
of the submembranous layer. It is hypothesized that when
sodium is in the high physiological range, filamentous actin
dominates over monomeric actin. This would explain the
sodium-induced increase in cell stiffness. When potassium is
elevated, actin filaments disaggregate into actin monomers
and endothelial cells soften. Both F-actin and G-actin are
negatively charged molecules and their interaction with Naþ
and Kþ will finally depend on the local concentrations and
specific affinities of the respective ions. It has to be kept in
mind that theses changes are supposed to take place in a
relatively restricted cytosolic space, directly beneath the
plasma membrane, most likely at the caveolae.1 As this
cytosolic submembranous zone (cell shell) is only a few
hundred nanometers thick, it is implied that about 90% of
the cell’s body remains uninvolved.
The solation–gelation hypothesis, based on the different
interaction between sodium and potassium with the
submembranous actin network, is supported by the observa-
tion that sodium has a greater affinity to protein surfaces
than potassium.25 It is assumed that when sodium enters the
cell (e.g., through ENaC activation) it binds with high affinity
to actin displacing potassium from the carboxylate groups
within the amino-acid side chains. Thus, increasing the
concentration of sodium, which has a higher affinity to actin
as compared to potassium, effectively modulates its pro-
tein–protein interaction strength.25 Such small changes in
sodium or potassium in the submembranous zone should
control the state of actin polymerization and thus the cell
stiffness and functionality (Figure 5).
‘ELECTRIC FIELD’ HYPOTHESIS
The membrane potential of endothelial cells is highly variable.26
One factor that may cause this variability is a change in
potassium flux across the cell membrane. At low extracellular
potassium concentrations, an increase can, paradoxically, hyper-
polarize the membrane potential of endothelial cells.27 Such a
change in membrane potential may directly or indirectly affect
the state of polymerization of the submembranous actin
network and thus modify the cell’s stiffness.28
There is a link between the plasma membrane potential
and NO synthesis. In human vascular endothelial cells,
calcium-activated potassium channels directly control NO
synthesis.29 Activation of these channels hyperpolarizes the
endothelial cell leading to increased eNOS activity. In this
functional state the cell is soft, that is, beneath the plasma
membrane G-actin dominates over F-actin.
In contrast, active ENaCs depolarize the endothelial cell. In
this functional state the cell is stiff, that is, F-actin dominates
over G-actin. Cell stiffening can be prevented by amiloride, a
diuretic that blocks ENaC and hyperpolarizes the endothelial
cell, or by spironolactone, an aldosterone receptor blocker that
prevents ENaC from being expressed in the endothelium.30
CLINICAL PERSPECTIVES
The finding that endothelial cells modify their function
in response to changes in the extracellular concentration
of sodium and potassium (Figure 6) could trigger new
approaches in the diagnosis and therapy of cardiovascular
disease. The control of local tissue perfusion strongly depends
on the local environment that includes electrolyte concentra-
tions that differ depending on the metabolic activity of the
respective site or organ. It seems promising to test ion
channel blockers and agonists, well known to exert their
effects on various epithelia, including vascular endothelium.
It may turn out that some of the actions of such substances
are due to alterations of vascular function rather than to
modifications of epithelial transport.
Cell shell with eNOS
Extracellular
Intracellular
G-actin
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Figure 5 |Hypothesis for how sodium and potassium control
the fluidity of the cortical zone (‘cell shell’) in an endothelial cell.
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Figure 6 |Concept of how sodium, potassium, and
aldosterone contribute to the regulation of blood vessel tone.
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